Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status.
Anni SjöblomUlf-Håkan StenmanJaana HagströmLauri JouhiCaj HaglundStina M SyrjänenPetri MattilaAntti Aarni MäkitieTimo CarpénPublished in: Cancers (2021)
Our results suggest that S-TATI positivity may be a biomarker of poor prognosis in both HPV-positive and HPV-negative OPSCC.